Pricing Log in Create free account

Incyte Corporation (INCY) vs BeOne Medicines Ltd. - Sponsored ADR (ONC)

Incyte Corporation and BeOne Medicines Ltd. - Sponsored ADR are both Biotechnology companies. BeOne Medicines Ltd. - Sponsored ADR is the larger, with a market value of $39.0B against $23.0B — 1.7× the size. Incyte Corporation trades at the lower P/E: 13.9× against 62.6×. BeOne Medicines Ltd. - Sponsored ADR grew revenue faster over the last twelve months: 34.4% against 26.9%. Incyte Corporation has the higher net margin (27.7% vs 10.7%) and the higher return on invested capital (60.5% vs 60.2%). Across the 21 metrics below, Incyte Corporation leads on 18 and BeOne Medicines Ltd. - Sponsored ADR on 3.

Valuation

Metric INCY ONC Biotechnology median
P/E 13.89 62.55 8.50
P/S 3.89 6.72 9.71
P/B 3.57 7.96 2.13
Price to free cash flow 11.97 31.43 20.82
EV/EBITDA 9.66 34.59 0.64
EV/Sales 3.12 6.08 9.21
Earnings yield 7.20% 1.60% (33.15%)
Free cash flow yield 8.35% 3.18% (25.50%)

Profitability

Metric INCY ONC Biotechnology median
Gross margin 92.62% 88.89% 65.16%
Operating margin 30.56% 15.06% 0.00%
Net margin 27.71% 10.70% 0.00%
Free cash flow margin 32.48% 21.70% 0.00%
Return on equity 30.67% 14.66% (56.36%)
Return on assets 23.55% 8.47% (48.04%)
Return on invested capital 60.50% 60.22% 0.00%

Growth

Metric INCY ONC Biotechnology median
Revenue growth (TTM) 26.93% 34.35% 6.02%
EPS growth (last fiscal year) 4,173.33% 141.34% 30.26%
Revenue growth, 5-year CAGR 14.03% 76.85% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INCY ONC Biotechnology median
Debt to equity 0.00 0.17 0.00
Current ratio 4.59 3.41 4.72
Net debt to EBITDA (2.21) (6.09) 0.96

Dividend

Metric INCY ONC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric INCY ONC Biotechnology median
Market cap 22.96b 39.01b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack